UniProt ID | ZCHC7_HUMAN | |
---|---|---|
UniProt AC | Q8N3Z6 | |
Protein Name | Zinc finger CCHC domain-containing protein 7 | |
Gene Name | ZCCHC7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 543 | |
Subcellular Localization | Nucleus, nucleolus . | |
Protein Description | ||
Protein Sequence | MMFGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIREEEHEEKNSGNSESSSSKPNQKKLIVLSDSEVIQLSDGSEVITLSDEDSIYRCKGKNVRVQAQENAHGLSSSLQSNELVDKKCKSDIEKPKSEERSGVIREVMIIEVSSSEEEESTISEGDNVESWMLLGCEVDDKDDDILLNLVGCENSVTEGEDGINWSISDKDIEAQIANNRTPGRWTQRYYSANKNIICRNCDKRGHLSKNCPLPRKVRRCFLCSRRGHLLYSCPAPLCEYCPVPKMLDHSCLFRHSWDKQCDRCHMLGHYTDACTEIWRQYHLTTKPGPPKKPKTPSRPSALAYCYHCAQKGHYGHECPEREVYDPSPVSPFICYYDDKYEIQEREKRLKQKIKVLKKNGVIPEPSKLPYIKAANENPHHDIRKGRASWKSNRWPQENKETQKEMKNKNRNWEKHRKADRHREVDEDFPRGPKTYSSPGSFKTQKPSKPFHRSSHYHTSREDKSPKEGKRGKQKKKERCWEDDDNDNLFLIKQRKKKS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MMFGGYETIEAYE --CCCCCCCHHHHHH | 15.41 | 23663014 | |
8 | Phosphorylation | MMFGGYETIEAYEDD CCCCCCCHHHHHHHC | 18.68 | 23663014 | |
12 | Phosphorylation | GYETIEAYEDDLYRD CCCHHHHHHHCCCCC | 13.70 | 23663014 | |
17 | Phosphorylation | EAYEDDLYRDESSSE HHHHHCCCCCCCCCC | 24.02 | 23663014 | |
64 | Phosphorylation | KNSGNSESSSSKPNQ HHCCCCCCCCCCCCC | 35.03 | - | |
65 | Phosphorylation | NSGNSESSSSKPNQK HCCCCCCCCCCCCCC | 34.28 | 28985074 | |
66 | Phosphorylation | SGNSESSSSKPNQKK CCCCCCCCCCCCCCE | 52.22 | - | |
67 | Phosphorylation | GNSESSSSKPNQKKL CCCCCCCCCCCCCEE | 54.82 | - | |
78 | Phosphorylation | QKKLIVLSDSEVIQL CCEEEEECCCCEEEC | 28.35 | 26074081 | |
80 | Phosphorylation | KLIVLSDSEVIQLSD EEEEECCCCEEECCC | 30.32 | 26074081 | |
120 | Phosphorylation | QENAHGLSSSLQSNE EHHHCCCCHHHHHCH | 23.60 | 30108239 | |
121 | Phosphorylation | ENAHGLSSSLQSNEL HHHCCCCHHHHHCHH | 39.86 | 29743597 | |
122 | Phosphorylation | NAHGLSSSLQSNELV HHCCCCHHHHHCHHH | 27.35 | 29743597 | |
125 | Phosphorylation | GLSSSLQSNELVDKK CCCHHHHHCHHHHHH | 37.25 | 29743597 | |
130 (in isoform 2) | Ubiquitination | - | 58.27 | 21906983 | |
131 | Ubiquitination | QSNELVDKKCKSDIE HHCHHHHHHCHHHCC | 53.22 | 2190698 | |
131 (in isoform 1) | Ubiquitination | - | 53.22 | 21906983 | |
131 | Sumoylation | QSNELVDKKCKSDIE HHCHHHHHHCHHHCC | 53.22 | 28112733 | |
131 | Acetylation | QSNELVDKKCKSDIE HHCHHHHHHCHHHCC | 53.22 | 26051181 | |
132 | Ubiquitination | SNELVDKKCKSDIEK HCHHHHHHCHHHCCC | 42.29 | - | |
139 | Sumoylation | KCKSDIEKPKSEERS HCHHHCCCCCCHHCC | 59.07 | 28112733 | |
141 | Sumoylation | KSDIEKPKSEERSGV HHHCCCCCCHHCCCC | 79.96 | 28112733 | |
141 | Sumoylation | KSDIEKPKSEERSGV HHHCCCCCCHHCCCC | 79.96 | - | |
142 | Phosphorylation | SDIEKPKSEERSGVI HHCCCCCCHHCCCCE | 53.90 | 25159151 | |
159 | Phosphorylation | VMIIEVSSSEEEEST EEEEEECCCCCCCCC | 47.12 | 22210691 | |
166 | Phosphorylation | SSEEEESTISEGDNV CCCCCCCCCCCCCCC | 31.63 | 22210691 | |
226 | Phosphorylation | AQIANNRTPGRWTQR HHHHCCCCCCHHHHH | 32.02 | 25159151 | |
231 | Phosphorylation | NRTPGRWTQRYYSAN CCCCCHHHHHHHCCC | 11.21 | 28555341 | |
236 | Phosphorylation | RWTQRYYSANKNIIC HHHHHHHCCCCCEEE | 19.21 | 29214152 | |
239 | Acetylation | QRYYSANKNIICRNC HHHHCCCCCEEECCC | 49.60 | 26051181 | |
239 | Sumoylation | QRYYSANKNIICRNC HHHHCCCCCEEECCC | 49.60 | 28112733 | |
239 | Ubiquitination | QRYYSANKNIICRNC HHHHCCCCCEEECCC | 49.60 | - | |
239 | Sumoylation | QRYYSANKNIICRNC HHHHCCCCCEEECCC | 49.60 | - | |
254 | Sumoylation | DKRGHLSKNCPLPRK CCCCCCCCCCCCCHH | 69.77 | 28112733 | |
276 | Phosphorylation | SRRGHLLYSCPAPLC CCCCEEEECCCCCCC | 18.00 | 22210691 | |
277 | Phosphorylation | RRGHLLYSCPAPLCE CCCEEEECCCCCCCC | 17.37 | 22210691 | |
295 | Phosphorylation | VPKMLDHSCLFRHSW CCCCCCCCHHHCCCH | 16.51 | 22210691 | |
326 | Phosphorylation | CTEIWRQYHLTTKPG HHHHHHHHCCCCCCC | 7.10 | 20068231 | |
329 | Phosphorylation | IWRQYHLTTKPGPPK HHHHHCCCCCCCCCC | 21.33 | 20068231 | |
330 | Phosphorylation | WRQYHLTTKPGPPKK HHHHCCCCCCCCCCC | 41.42 | 20068231 | |
331 | Sumoylation | RQYHLTTKPGPPKKP HHHCCCCCCCCCCCC | 42.62 | - | |
331 | Sumoylation | RQYHLTTKPGPPKKP HHHCCCCCCCCCCCC | 42.62 | - | |
339 | Sumoylation | PGPPKKPKTPSRPSA CCCCCCCCCCCCHHH | 80.22 | 28112733 | |
340 | Phosphorylation | GPPKKPKTPSRPSAL CCCCCCCCCCCHHHH | 34.72 | 25159151 | |
342 | Phosphorylation | PKKPKTPSRPSALAY CCCCCCCCCHHHHHH | 63.15 | 30576142 | |
345 | Phosphorylation | PKTPSRPSALAYCYH CCCCCCHHHHHHHHH | 34.50 | 28555341 | |
384 | Ubiquitination | FICYYDDKYEIQERE EEEECCCHHHHHHHH | 41.72 | - | |
403 | Methylation | QKIKVLKKNGVIPEP HHHHHHHHCCCCCCC | 55.56 | - | |
403 | Trimethylation | QKIKVLKKNGVIPEP HHHHHHHHCCCCCCC | 55.56 | - | |
412 | Sumoylation | GVIPEPSKLPYIKAA CCCCCCCCCCCEECC | 65.28 | 28112733 | |
412 | Sumoylation | GVIPEPSKLPYIKAA CCCCCCCCCCCEECC | 65.28 | - | |
412 | Methylation | GVIPEPSKLPYIKAA CCCCCCCCCCCEECC | 65.28 | - | |
417 | Sumoylation | PSKLPYIKAANENPH CCCCCCEECCCCCCC | 35.29 | - | |
417 | Ubiquitination | PSKLPYIKAANENPH CCCCCCEECCCCCCC | 35.29 | - | |
417 | Sumoylation | PSKLPYIKAANENPH CCCCCCEECCCCCCC | 35.29 | 28112733 | |
433 | Phosphorylation | DIRKGRASWKSNRWP CHHHCCHHHHHCCCC | 33.41 | 24719451 | |
435 | Sumoylation | RKGRASWKSNRWPQE HHCCHHHHHCCCCCC | 35.04 | 28112733 | |
435 | Sumoylation | RKGRASWKSNRWPQE HHCCHHHHHCCCCCC | 35.04 | - | |
444 | Sumoylation | NRWPQENKETQKEMK CCCCCCCHHHHHHHH | 62.48 | - | |
444 | Sumoylation | NRWPQENKETQKEMK CCCCCCCHHHHHHHH | 62.48 | - | |
478 | Sumoylation | EDFPRGPKTYSSPGS CCCCCCCCCCCCCCC | 64.02 | 28112733 | |
479 | Phosphorylation | DFPRGPKTYSSPGSF CCCCCCCCCCCCCCC | 31.59 | 29396449 | |
480 | Phosphorylation | FPRGPKTYSSPGSFK CCCCCCCCCCCCCCC | 17.18 | 30108239 | |
481 | Phosphorylation | PRGPKTYSSPGSFKT CCCCCCCCCCCCCCC | 34.98 | 30266825 | |
482 | Phosphorylation | RGPKTYSSPGSFKTQ CCCCCCCCCCCCCCC | 23.90 | 30266825 | |
485 | Phosphorylation | KTYSSPGSFKTQKPS CCCCCCCCCCCCCCC | 27.27 | 30266825 | |
487 | Sumoylation | YSSPGSFKTQKPSKP CCCCCCCCCCCCCCC | 52.31 | - | |
487 | Sumoylation | YSSPGSFKTQKPSKP CCCCCCCCCCCCCCC | 52.31 | 28112733 | |
490 | Sumoylation | PGSFKTQKPSKPFHR CCCCCCCCCCCCCCC | 57.39 | - | |
490 | Sumoylation | PGSFKTQKPSKPFHR CCCCCCCCCCCCCCC | 57.39 | 28112733 | |
493 | Sumoylation | FKTQKPSKPFHRSSH CCCCCCCCCCCCCCC | 61.30 | - | |
493 | Sumoylation | FKTQKPSKPFHRSSH CCCCCCCCCCCCCCC | 61.30 | 28112733 | |
537 | Sumoylation | NDNLFLIKQRKKKS- CCCEEEEEECCCCC- | 46.31 | - | |
537 | Ubiquitination | NDNLFLIKQRKKKS- CCCEEEEEECCCCC- | 46.31 | - | |
537 | Sumoylation | NDNLFLIKQRKKKS- CCCEEEEEECCCCC- | 46.31 | 28112733 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZCHC7_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZCHC7_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZCHC7_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PAPD5_HUMAN | PAPD5 | physical | 21878619 | |
PAPD7_HUMAN | PAPD7 | physical | 21878619 | |
PDLI7_HUMAN | PDLIM7 | physical | 26186194 | |
VIGLN_HUMAN | HDLBP | physical | 26186194 | |
SENP5_HUMAN | SENP5 | physical | 26186194 | |
IF2B_HUMAN | EIF2S2 | physical | 26186194 | |
HDGR2_HUMAN | HDGFRP2 | physical | 26186194 | |
BCD1_HUMAN | ZNHIT6 | physical | 26186194 | |
TASOR_HUMAN | FAM208A | physical | 26186194 | |
PDLI7_HUMAN | PDLIM7 | physical | 28514442 | |
HDGR2_HUMAN | HDGFRP2 | physical | 28514442 | |
SENP5_HUMAN | SENP5 | physical | 28514442 | |
ZKSC1_HUMAN | ZKSCAN1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-482, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-482, AND MASSSPECTROMETRY. |